ID   HL-7702BaPT
AC   CVCL_WN40
DR   CCRID; 4201PAT-CCTCC00571
DR   Wikidata; Q94211708
RX   Patent=CN105802915B;
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. Parent cell line (L-02) has been shown to be a HeLa derivative.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014243.
CC   Population: African American.
CC   Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6926 ! L-02
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
RX   Patent=CN105802915B;
RA   Wang H., Ba G., Li J.-Q.;
RT   "Cell model having undergone vicious transformation.";
RL   Patent number CN105802915B, 09-Aug-2019.
//